Early Histopathologic and Ultrastructural Changes in the Heart of Sprague-Dawley Rats Following Administration of Soman

Toxicologic Pathology

Volumn 24, Issue 2, 1996, Pages 190-198

  Tryphonas, Leander ^a   Veinot, John P ^b   Clement, John G ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Canada TIA 8K6   (United States)

Author keywords

Catecholamines; cholinesterase inhibitors; encephalocardiomyopathy; hypercontraction; hyperextension; myocytolysis; toxic cardiomyopathy

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ATROPINE METHYL NITRATE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL ORGANELLE; CONTROLLED STUDY; CYTOLYSIS; ELECTRON MICROSCOPY; HEART CONTRACTION; HEART MITOCHONDRION; HISTOPATHOLOGY; MALE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMERE; SEIZURE;

ANIMALS; ATROPINE; CATECHOLAMINES; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; MALE; MYOCARDIUM; MYOFIBRILS; PARASYMPATHOLYTICS; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SARCOMERES; SEIZURES; SOMAN;

ANIMALIA;

EID: 0029997525     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400207     Document Type: Article

References (58)

1. Anichkov SV and Vedeneyeva ZI (1961). Irritation of the sympathetic nerve as a cause of myocardial lesions. Acta Physiol. Hung. 19: 17-18.
2. Ariens AT, Meeter E., and Wolthuis OL (1969). Reversible necrosis at the end-plate region in the striated muscles of the rat poisoned with cholinesterase inhibitors. Experientia 25: 57-59.
3. Baskin SI and Whitmer MP (1991). The cardiac toxicology of organophosphorus agents. In: Principles of Cardiac Toxicology, SI Baskin (ed). CRC Press, Boca Raton, Florida, pp. 275-293.
4. Baze WB (1993). Soman-induced morphological changes-An overview in the non-human primate. J. Appl. Toxicol. 13: 173-177.
5. Baze WB, Anderson DR, Harris LW, Lennox WJ, Bowersox SL, and Solana RP (1991). Soman-induced brain and heart lesions in the rat: Effects of antidotal and anticonvulsant therapy. Proc. 1991 Med. Def. Biosci. Rev. Aug 7-8.
6. Bloom S. and Cancilla PA (1969). Myocytolysis and mitochondrial calcification after low doses of isoproterenol. Am. J. Pathol. 54: 373-391.
7. Broomfield CA, Lenz DE, and Maciver B. (1986). The stability of soman and its stereoisomers in aqueous solution: Toxicological considerations. Arch. Toxicol. 59: 261-265.
8. Burch GE, Sun SC, Colcolough HC, et al (1967). Acute myocardial lesions following experimentally-induced intracranial hemorrhage in mice: A histological and histochemical study. Arch. Pathol. 84: 517-521.
9. Carpentier P., Lambrinidis M., and Blanchet G. (1991). Early dendritic changes in hippocampal pyramidal neurones (field CA1) of rats subjected to acute soman intoxication-A light microscopic study. Brain Res. 541: 293-299.
10. Chappel CL, Rona G., and Balazs T. (1959). Comparison of cardiotoxic actions of certain sympathomimetic amines. Can. J. Biochem. Physiol. 37: 35-42.
11. Churchill L., Pazdernik TL, Jackson JL, Nelson SR, McDonough JH, and McLeod CG (1985). Soman induced brain lesions demonstrated by muscarinic receptor autoradiography. NeuroToxicology 6: 81-90.
12. Clement JG and Broxup B. (1993). Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. NeuroToxicology 14: 485-504.
13. Clement JG and Lee MJ (1980). Soman-induced convulsions: Significance of changes in levels of blood erythrocytes, gases, glucose, and insulin. Toxicol. Appl. Pharmacol. 55: 203-204.
14. DeGroot DMG, Bierman EPB, and Van Huygenvoort AHBM (1990). Involvement of acetylcholine and glutamate in soman-induced brain damage. Micron Microscopia Acta 21: 247-248.
15. Filbert MG, Dochterman LW, Smith CD, Forster JS, Phann S., and Cann FJ (1993). Effect of mannitol treatment on soman-induced brain and heart lesions in the rat. Drug. Dev. Res. 30: 45-53.
16. Fleckenstein A. (1976). Specific inhibitors and promoters of Ca2+ action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart, P Harris and L Opie (eds). Academic Press, New York, pp. 135-188.
17. Fleckenstein A., Janke J., Doring HJ, and Leder O. (1974). Myocardial fibre necrosis due to intracellular calcium overload-A new principle in cardiac physiology. Rec. Adv. Struct. Metab. 4: 563-580.
18. Fleckenstein A., Janke J., Doring HJ, and Pachinger O. (1973). Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. Rec. Adv. Stud. Card. Metab. 2: 455-466.
19. Fleckenstein A., Pachinger O., Leder O., Hein B., and Janke J. (1971). Verhutung isoproterenol-induzierter myocardnekrosen durch senkung der plasmacalcium-speigels mittles calcitonin. Pflugers Arch. 332(suppl. 332): R40.
20. Gibbons WR (1986). Cellular control of cardiac contraction. In: The Heart and Cardiovascular System, HA Fozzard, E Haber, RB Jennings, AM Katz, and HE Morgan (eds). Raven Press, New York, pp.747-778.
21. Greenhoot JH and Reichenbach DD (1969). Cardiac injury and sub-arachnoid hemorrhage. A clinical, pathological, and physiological correlation. J. Neurosurg. 30: 521-531.
22. Gupta RC, McLean MJ, and Dettbarn WD (1987). Prophylaxis and treatment against the toxicity of organophosphate (op) compounds in rat by memantine and atropine. Toxicologist 7: 276.
23. Hawkins WE and Clower BR (1971). Myocardial damage after head trauma and simulated intracranial hemorrhage in mice: The role of the autonomic nervous system. Cardiovasc. Res. 5: 524-529.
24. Hayward IJ, Wall HG, Jaax NK, Wade JV, Marlow DD, and Nold JB (1990). Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98: 99-106.
25. Juhasz-Nagy A., Szentivanyi M., Ovary I., and Debreczeni L. (1965). Hypothalamic control of coronary circulation in the dog. Arch. Int. Physiol. Biochem. 73: 798-816.
26. Junqueira LC and Carneiro J. (1971). Basic Histology. LANGE Medical Publications, Los Altos, California.
27. Kadar T., Cohen G., Sahar R., Alkalai D., and Shapira S. (1992). Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum. Exp. Toxicol. 11: 517-523.
28. King JM, Roth L., and Haschek WM (1982). Myocardial necrosis secondary to neural lesions in domestic animals. J. Am. Vet. Med. Assoc. 180: 144-148.
29. Klouda MA and Brynjolfsson G. (1969). Cardiotoxic effects of electrical stimulation of the stellate ganglia. Ann. N.Y. Acad. Sci. 156: 271-280.
30. Lallement G., Carpentier P., Collet A., Baubichon D., Pernotmarino I., and Blanchet G. (1992). Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. NeuroToxicology 13: 557-567.
31. Lallement G., Delamanche IS, Pernotmarino I., Baubichon D., Denoyer M., Carpentier P., and Blanchet G. (1993). Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage-Quantification with an omega-3 site ligand. Brain Res. 618: 227-237.
32. Lallement G., Denoyer M., Collet A., Pernotmarino I., Baubichon D., Monmaur P., and Blanchet G. (1992). Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures-Influence of septal cholinoceptive cells. Neurosci. Lett. 139: 104-107.
33. Lemercier G., Carpentier P., Sentenac-Roumanou H., and Morelis P. (1983). Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol.(Berlin) 61: 123-129.
34. Lipp JA (1968). Cerebral electrical activity following soman administration. Arch. Int. Pharmacodyn. Ther. 175: 161-169.
35. McDonough JH, Hackley BE, Cross R., Samson F., and Nelson S. (1983). Brain regional glucose use during soman-induced seizures. NeuroToxicology 4: 203-210.
36. McDonough JH, Jaax NK, Crowley RA, Mays MZ, and Modrow HE (1989). Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fund. Appl. Toxicol. 13: 256-276.
37. McDonough JH, McLeod CG, and Nipwoda MT (1987). Direct microinjection of soman or vx into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 435: 123-137.
38. McLeod CG (1985). Pathology of nerve agents: Perspectives on medical management. Fund. Appl. Toxicol. 5: s10-s16.
39. McLeod CG, Singer AW, and Harrington DG (1984). Acute neuropathology in soman poisoned rats. NeuroToxicology 5: 53-58.
40. McNair JL, Clower BR, and Sandford RA (1970). The effect of reserpine pretreatment on myocardial damage associated with simulated intracranial hemorrhage in mice. Eur. J. Pharmacol. 9: 1-6.
41. Moreva E. (1980). Methods for producing experimental neurogenic lesions. In: Neurogenic Heart Lesions, IS Zavodskaya, EV Moreva, and NA Novikova (eds). Pergamon Press, Oxford, pp. 9-22.
42. Oppenheimer S. (1992). The insular cortex and the pathophysiology of stroke-induced cardiac changes. Can. J. Neurol. Sci. 19: 208-211.
43. Pazdernik TL, Cross R., Giesler M., Samson F., and Nelson S. (1985). Changes in local cerebral glucose utilization induced by convulsants. Neuroscience 14: 823-835.
44. Rockhold R. (1991). Cardiotoxicity of naturally occurring catecholamines. In: Principles of Cardiac Toxicology, SI Baskin (ed). CRC Press, Boca Raton, Florida pp. 347-417.
45. Rodwell VW, Murray RK, and Keeley FW (1990). Contractile and structural proteins. In: Harper's Biochemistry, RK Murray, DK Granner, PA Mayes, and VW Rodwell (eds). Appleton and Lange, San Mateo, California, pp. 627-644.
46. Rona G., Huttner I., and Boutet M. (1977). Microcirculatory changes in myocardium with particular reference to catecholamine-induced cardiac muscle cell injury. In: Handbuch der Allgemeinen Pathologie, Vol. III, H Meesen (ed). Springer-Verlag, Berlin, pp. 791-888.
47. Roth A., Zellinger I., Arad M., and Atsmon J. (1993). Organophosphates and the heart. Chest 103: 576-582.
48. Schenk EA and Moss AJ (1966). Cardiovascular effects of sustained norepinephrine infusions. II Morphology. Circulation Res. 18: 605-615.
49. Shih TM (1982). Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology 78: 170-175.
50. Shih TM, Penetar DM, Mcdonough JH, Romano JA, and King JM (1990). Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity. Brain Res. Bull. 24: 429-436.
51. Singal PK, Dhillon KS, Beamish RE, and Dhalla NS (1981). Protective effect of zinc against catecholamine-induced myocardial changes: Electrocardiographic and ultrastructure studies. Lab. Invest. 44: 426-433.
52. Singal PK, Kapur N., Dhillon KS, Beamish RE, and Dhalla NS (1982). Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60: 1390-1397.
53. Singal PK, Panagia V., Beamish RE, and Dhalla NS (1985). Role of calcium in heart function in health and disease. In: Calcium in Biological Systems, RP Rubin, GB Weiss, and JW Putney (eds). Plenum Press, New York, pp. 361-368.
54. Singer AW, Jaax NK, Graham JS, and McLeod CG (1987). Cardiomyopathy in soman and sarin intoxicated rats. Toxicol Lett. 36: 243-249.
55. Tower D. (1988). Development of the knowledge of atrocytes since Virchow. In: Biochemical Pathology of Astrocytes, MD Norenberg, L Hertz, and A Schousboe (eds). Alan R. Liss, New York, pp. 3-18.
56. Tryphonas L. and Clement JG (1993). Dose and time related effects on the CNS and heart of rats exposed to a single dose of soman: A histopathological study. U.S. Army 1993 Med. Def. Biosci. Rev. May 10-13, Baltimore, Maryland, pp. 685-694.
57. Tryphonas L. and Clement JG (1995). Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprague-Dawley rats. Toxicol. Pathol. 23: 393-409.
58. Weilder DJ (1974). Myocardial damage and cardiac arrhythmias after intracranial hemorrhage. A critical review. Stroke 20: 133-183.